Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piero Picci

Showing results (41-50 of 272) with videos related to

Pageof 28
Sort By:
Expert Opinion on Emerging Drugs|May 30, 2015
Advances in emerging drugs for osteosarcomaClaudia Maria Hattinger, Marilù Fanelli, Elisa Tavanti, et al.
European Journal of Radiology|September 11, 2010
Late sarcoma development after curettage and bone grafting of benign bone tumorsPiero Picci, Gabriela Sieberova, Marco Alberghini, et al.
Expert Review of Molecular Diagnostics|October 17, 2018
Genetic testing for high-grade osteosarcoma: a guide for future tailored treatments?Claudia Maria Hattinger, Maria Pia Patrizio, Elisa Tavanti, et al.
Journal of Pediatric Hematology/Oncology|January 10, 2009
Neoadjuvant chemotherapy for osteosarcoma of the extremities in preadolescent patients: the Rizzoli Institute experienceGaetano Bacci, Alba Balladelli, Emanuela Palmerini, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 12, 2010
Centrosome abnormalities in giant cell tumour of bone: possible association with chromosomal instabilityLinda Moskovszky, Katalin Dezsö, Nick Athanasou, et al.
ISRN Oncology|November 16, 2011
High Expression of Complement Component 5 (C5) at Tumor Site Associates with Superior Survival in Ewing's Sarcoma Family of Tumour PatientsSuvi Savola, Arto Klami, Samuel Myllykangas, et al.
Clinical Sarcoma Research|January 29, 2013
Solitary fibrous tumors of the soft tissues: imaging features with histopathologic correlationsZafaria G Papathanassiou, Marco Alberghini, Piero Picci, et al.
Frontiers in Endocrinology|May 8, 2018
Insulin-Like Growth Factor 2 mRNA-Binding Protein 3 Influences Sensitivity to Anti-IGF System Agents Through the Translational Regulation of <i>IGF1R</i>Caterina Mancarella, Michela Pasello, Maria Cristina Manara, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|January 23, 2015
Difficulty distinguishing benign notochordal cell tumor from chordoma further suggests a link between themJennifer Kreshak, Frédérique Larousserie, Piero Picci, et al.
Human Pathology|August 22, 2016
p16 expression as a prognostic and predictive marker in high-grade localized osteosarcoma of the extremities: an analysis of 357 casesAlberto Righi, Marco Gambarotti, Marta Sbaraglia, et al.
Pageof 28

Showing results (41-50 of 272) with videos related to

Sort By:
Pageof 28
Expert Opinion on Emerging Drugs|May 30, 2015
Advances in emerging drugs for osteosarcomaClaudia Maria Hattinger, Marilù Fanelli, Elisa Tavanti, et al.
European Journal of Radiology|September 11, 2010
Late sarcoma development after curettage and bone grafting of benign bone tumorsPiero Picci, Gabriela Sieberova, Marco Alberghini, et al.
Expert Review of Molecular Diagnostics|October 17, 2018
Genetic testing for high-grade osteosarcoma: a guide for future tailored treatments?Claudia Maria Hattinger, Maria Pia Patrizio, Elisa Tavanti, et al.
Journal of Pediatric Hematology/Oncology|January 10, 2009
Neoadjuvant chemotherapy for osteosarcoma of the extremities in preadolescent patients: the Rizzoli Institute experienceGaetano Bacci, Alba Balladelli, Emanuela Palmerini, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 12, 2010
Centrosome abnormalities in giant cell tumour of bone: possible association with chromosomal instabilityLinda Moskovszky, Katalin Dezsö, Nick Athanasou, et al.
ISRN Oncology|November 16, 2011
High Expression of Complement Component 5 (C5) at Tumor Site Associates with Superior Survival in Ewing's Sarcoma Family of Tumour PatientsSuvi Savola, Arto Klami, Samuel Myllykangas, et al.
Clinical Sarcoma Research|January 29, 2013
Solitary fibrous tumors of the soft tissues: imaging features with histopathologic correlationsZafaria G Papathanassiou, Marco Alberghini, Piero Picci, et al.
Frontiers in Endocrinology|May 8, 2018
Insulin-Like Growth Factor 2 mRNA-Binding Protein 3 Influences Sensitivity to Anti-IGF System Agents Through the Translational Regulation of <i>IGF1R</i>Caterina Mancarella, Michela Pasello, Maria Cristina Manara, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|January 23, 2015
Difficulty distinguishing benign notochordal cell tumor from chordoma further suggests a link between themJennifer Kreshak, Frédérique Larousserie, Piero Picci, et al.
Human Pathology|August 22, 2016
p16 expression as a prognostic and predictive marker in high-grade localized osteosarcoma of the extremities: an analysis of 357 casesAlberto Righi, Marco Gambarotti, Marta Sbaraglia, et al.
Pageof 28